Professional Media briefs
Thomson Reuters acquired GeneGo, a San Diego-based firm that provides biology and disease information, analytics and decision support services for pharma R&D. GeneGo will be folded into Thomson Reuters' Healthcare & Science business. The acquisition bolsters Thomson Reuters' drug pipeline competitive intelligence, patents and chemistry offerings with GeneGo's expertise in science, particularly on biologics. In addition to its San Diego headquarters, GeneGo has offices in Moscow and Michigan.
Elsevier dropped the “Cytogenetics” from its Cancer Genetics and Cytogenetics journal, and tapped a new editor-in-chief. The first issue with the shortened title, Cancer Genetics, goes out this month, with Jaclyn Biegel at the helm. The title change reflects a broader aim and scope for the journal, with a new focus on diagnostic applications and genetic predisposition of cancer, according to a statement.